SABMiller exec buys a round

Jan 24, 2012

Share with
friends:

Comments (0) Print this article

The Managing Director of SABMiller's African division bought a round of shares just one day before the drinks giant announced it has signed a definitive transaction agreement with Anadolu Group and Anadolu Efes.

The agreement allows the firm to form a strategic alliance between the firm's divisions in Turkey, Russia, the Commonwealth of Independent States (CIS), Central Asia and the Middle East.

The terms of the agreement, announced back in October, mean that SABMiller will now transfer its Russian and Ukranian beer divisions (valued at $1.9bn) to Anadolu Efes, the fifth-largest European brewer and the world's sixth-largest Coca-Cola bottler. In return, SABMiller will hold a 24% equity stake in Andolu Efes.

Mark Bowman, 45, purchased 963 shares at 2,382.845p each.

Just a few days ago the brewer reported that its financial performance for the final quarter of 2011 had been in line with expectations.

However, the European and North American divisions were noticeably weak, with larger volumes in Europe falling 2% while in the US sales were down 3.3%.

Top Director Buys

Immupharma (IMM)

Director name: Mr Ajay Agrawal

Amount purchased: 62,169 @ 80.00p

Value: £49,735

Immupharma (IMM)

Director name: Dr Franco Di Muzio

Amount purchased: 60,950 @ 81.00p

Value: £49,370

Stobart Group Ltd. (STOB)

Director name: Mr Jesper Kjaedegaard

Amount purchased: 22,000 @ 122.80p

Value: £27,016

Mission Marketing Group (TMMG)

Director name: Mr Dylan Bogg

Amount purchased: 100,000 @ 15.12p

Value: £15,120

Mediterranean Oil & Gas (MOG)

Director name: Mr Miles Donnelly

Amount purchased: 225,000 @ 5.30p

Value: £11,925

NR

Comments (0)

Share with
friends:

Leave a comment

This will be the name displayed with your comment.

This helps us verify comments are genuine. It will not be displayed anywhere on the site and is stored confidentially.

Please keep your comment within 1,000 characters and relevant to the main topic. We encourage healthy debate, but we don't allow insults or bad language. Anything off topic or unpleasant, we'll remove. Enjoy the conversation! Thank you.

captcha To prevent spam-related comments please enter the characters shown in the 'Captcha' box to the left.

By leaving a comment you accept our terms and conditions.


FREE - MoneyWeek's daily investment emailJohn Stepek

Our free daily email, Money Morning, is an informative and enjoyable analysis of what's going on in the markets. Written by our Editor, John Stepek, and guest contributors.
Sign up FREE to Money Morning here.

>